At KnE Publishing, we aim to ensure everything we publish is ethically sound and complies with the policies and principles set out by:
We ask that all our authors comply with the following standards:
Any research involving humans must adhere to the Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. In addition, all research participants should be informed about the study's aims and any possible adverse effects of the intervention and written informed consent must be obtained from all participants.
Research involving animals must adhere to the National Institutes of Health guidelines for the care and use of laboratory animals. In addition, the authors must describe any anesthetic or surgical procedures used, as well as evidence that all possible steps were taken to avoid animal suffering at each stage of the experiment.
Approval for research involving humans or animals must be obtained from an institutional or local review board.
This information, the name of the review board, and approval numbers / codes should be stated in the manuscript.
Ethical considerations must be clearly addressed in the methods section.
The Journal reserves the right to request the related documents.
According to the International Committee of Medical Journal Editors (ICMJE), a clinical trial is “any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes”.
Authors of clinical trials are required to prospectively register their trial with one of the trial registries recognised by the ICMJE or World Health Organization.
The registration number of the trial and the name of the trial registry must be mentioned in the manuscript.
Medical Sciences requires a completed CONSORT 2010 checklist and flow diagram as a condition of submission when reporting the results of a randomized trial. Templates for these can be found on the CONSORT website, which also describes several CONSORT checklist extensions for different designs and types of data beyond two parallel-group trials. At a minimum, your article should report the content addressed by each item of the checklist. Meeting these basic reporting requirements will significantly improve the value of your trial report and may enhance its chances for eventual publication.
All manuscripts submitted to our journals are screened for plagiarism using the Crossref Similarity Check powered by iThenticate.
All conflicts of interest (including financial, personal, academic, and/or ideological) must be declared upon submission. If no conflicts exist, the authors should state this. It should be noted that editors and reviewers are likewise responsible for disclosing any conflicts of interest.
The Journal of Spine Practice has clear definitions of conflicts of interest and processes for handling conflicts of interest of authors, reviewers, editors, journals and publishers, whether identified before or after publication.
The Journal of Spine Practice adheres to the conflict of interest definition outlined by Paul Romain, who states that "Circumstances that create a risk that professional judgments or actions regarding a primary interest will be unduly influenced by a secondary interest" (https://doi.org/10.1007/s12178-015-9270-2).
The Journal of Spine Practice follows the COPE flowcharts for the following scenarios of suspected nondisclosure of conflicts of interest:
This journal adheres to the Guidelines for retracting articles published by the Committee on Publication Ethics (COPE).
A retraction may be considered in cases such as:
The Journal of Spine Practice draws from the guidelines presented by the Committee on Publication Ethics (COPE) to manage complaints and disputes. Should they arise, complaints and/or disputes may be directed to publishing@knowledgee.com.
The names and email addresses entered in this journal site will be used for the stated purposes of this journal.
Upon publishing, all authors will be automatically registered for content alerts from the publication. To stop receiving the alerts, authors can subsequently unsubscribe through the link provided in the email.
These email addresses will not be made available to any other party.